{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:20:03Z","timestamp":1769707203099,"version":"3.49.0"},"reference-count":224,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Influenza A virus (IAV) infection activates multiple programmed cell death (PCD) pathways, which, while restricting viral replication and dissemination, concurrently disrupt the respiratory epithelial barrier and compromise immune homeostasis. Excessive activation of apoptosis, necroptosis, pyroptosis, and related processes results in tight junction(TJ) disruption, impaired mucociliary clearance and gas exchange, and amplification of inflammatory cascades, ultimately driving cytokine storm and severe tissue injury. This dual role of PCD underscores its importance in antiviral defense while exposing its potential to exacerbate immunopathology. Accordingly, this review focuses on IAV-induced PCD mechanisms, delineating their contribution to epithelial barrier breakdown and immune dysregulation, with the aim of informing strategies for precise modulation of immunopathological damage and improving therapeutic outcomes in severe influenza.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1705500","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:43:12Z","timestamp":1769668992000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Orchestrating immunopathology: the spectrum of programmed cell death pathways co-opted by influenza a virus in pulmonary immunity"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuanyuan","family":"Luo","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingman","family":"He","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxiang","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Sichuan Provincial Engineering Technology Research Center of Natural Small Molecule Drug, Tianfu Traditional Chinese Medicine (TCM) Innovation Harbour, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yao","sequence":"additional","affiliation":[{"name":"Sichuan Provincial Engineering Technology Research Center of Natural Small Molecule Drug, Tianfu Traditional Chinese Medicine (TCM) Innovation Harbour, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"Sichuan Provincial Engineering Research Center of Innovative Re-Development of Famous Classical Formulas, Tianfu Traditional Chinese Medicine (TCM) Innovation Harbour, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza a viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.11.002","article-title":"Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities","volume":"355","author":"Stevens","year":"2006","journal-title":"J Mol Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1005544","DOI":"10.1371\/journal.ppat.1005544","article-title":"Influenza virus infects epithelial stem\/progenitor cells of the distal lung: impact on Fgfr2b-driven epithelial repair","volume":"12","author":"Quantius","year":"2016","journal-title":"PloS Pathog"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza a virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J Gen Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza a epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1154137","article-title":"The global circulation of seasonal influenza a (H3N2) viruses","volume":"320","author":"Russell","year":"2008","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2359470","article-title":"Research progress on the nonstructural protein 1 (NS1) of influenza a virus","volume":"15","author":"X","year":"2024","journal-title":"Virulence"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00879-10","article-title":"The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon","volume":"84","author":"Graef","year":"2010","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01217-07","article-title":"Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells","volume":"81","author":"Owen","year":"2007","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.915","article-title":"Enhanced recognition of human NK receptors after influenza virus infection","volume":"171","author":"Achdout","year":"2003","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797789","article-title":"Molecular events involved in influenza a virus-induced cell death","volume":"12","author":"Gui","year":"2021","journal-title":"Front Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.012","article-title":"The NLR family of innate immune and cell death sensors","volume":"57","author":"Sundaram","year":"2024","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.147","article-title":"Programmed cell death as a defence against infection","volume":"17","author":"I","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2099206","article-title":"Neutrophil autophagy and NETosis in COVID-19: perspectives","volume":"19","author":"Zhang","year":"","journal-title":"Autophagy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00245","article-title":"Respiratory influenza a virus infection triggers local and systemic natural killer cell activation via toll-like receptor 7","volume":"9","author":"Stegemann-Koniszewski","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.010","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2003.00493.x","article-title":"The airway epithelium: structural and functional properties in health and disease","volume":"8","author":"Knight","year":"2003","journal-title":"Respirol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"119536","DOI":"10.1016\/j.bbamcr.2023.119536","article-title":"Viral manipulation of cell polarity signalling","volume":"1870","author":"Javorsky","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2017.1278812","article-title":"C2-ceramide influences alveolar epithelial barrier function by downregulating zo-1, occludin and claudin-4 expression","volume":"27","author":"Yang","year":"2017","journal-title":"Toxicol Mech Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12035-013-8425-7","article-title":"Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway","volume":"48","author":"Lucas","year":"2013","journal-title":"Mol Neurobiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1465-9921-8-75","article-title":"Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation","volume":"8","author":"Mazzon","year":"2007","journal-title":"Respir Res"},{"key":"B27","article-title":"TNF-induced endothelial barrier disruption: beyond actin and rho","volume":"112","author":"Marcos-Ramiro","year":"2014","journal-title":"Thromb Haemost"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e982424","DOI":"10.4161\/21688370.2014.982424","article-title":"NF-\u03baB inhibitors impair lung epithelial tight junctions in the absence of inflammation","volume":"3","author":"Ward","year":"2015","journal-title":"Tissue Barriers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0449-8","article-title":"Allergic inflammatory memory in human respiratory epithelial progenitor cells","volume":"560","author":"Ordovas-Montanes","year":"2018","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0040122","DOI":"10.1128\/mbio.00401-22","article-title":"Emerging role of ZBP1 in Z-RNA sensing, influenza virus-induced cell death, and pulmonary inflammation","volume":"13","author":"Basavaraju","year":"2022","journal-title":"Mbio"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00370-7","article-title":"Cellular and functional heterogeneity of the airway epithelium","volume":"14","author":"Davis","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1242\/dev.083840","article-title":"Different assemblies of notch receptors coordinate the distribution of the major bronchial clara, ciliated and neuroendocrine cells","volume":"139","author":"Morimoto","year":"2012","journal-title":"Dev Camb Engl"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201592821","article-title":"GEMC1 is a critical regulator of multiciliated cell differentiation","volume":"35","author":"Terr\u00e9","year":"2016","journal-title":"EMBO J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"151189","DOI":"10.1016\/j.ejcb.2021.151189","article-title":"In vitro differentiation of ciliated cells in ALI-cultured human airway epithelium - the framework for functional studies on airway differentiation in ciliopathies","volume":"101","author":"Bukowy-Biery\u0142\u0142o","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.178","article-title":"Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism","volume":"25","author":"Nemajerova","year":"2018","journal-title":"Cell Death Differ"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1242\/dev.074666","article-title":"Switching on cilia: transcriptional networks regulating ciliogenesis","volume":"141","author":"Choksi","year":"2014","journal-title":"Dev Camb Engl"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.017","article-title":"NotcH2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung","volume":"10","author":"Danahay","year":"2015","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39731","article-title":"SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production","volume":"119","author":"Chen","year":"2009","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29176","article-title":"SPDEF regulates goblet cell hyperplasia in the airway epithelium","volume":"117","author":"Park","year":"2007","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.celrep.2015.06.011","article-title":"Clonal dynamics reveal two distinct populations of basal cells in slow-turnover airway epithelium","volume":"12","author":"Watson","year":"2015","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2011.04.003","article-title":"Notch-dependent differentiation of adult airway basal stem cells","volume":"8","author":"Rock","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700115R","article-title":"Early life allergen-induced mucus overproduction requires augmented neural stimulation of pulmonary neuroendocrine cell secretion","volume":"31","author":"Barrios","year":"2017","journal-title":"FASEB J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad7969","article-title":"Pulmonary neuroendocrine cells function as airway sensors to control lung immune response","volume":"351","author":"Branchfield","year":"2016","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1438188","article-title":"Pulmonary neuroendocrine cells: crucial players in respiratory function and airway-nerve communication","volume":"18","author":"Thakur","year":"2024","journal-title":"Front Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"dmm046920","DOI":"10.1242\/dmm.046920","article-title":"Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease","volume":"13","author":"Noguchi","year":"2020","journal-title":"Dis Model Mech"},{"key":"B48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcdb.2012.09.003","article-title":"Recent advances and contraversies on the role of pulmonary neuroepithelial bodies as airway sensors","volume":"24","author":"Cutz","year":"2013","journal-title":"Semin Cell Dev Biol"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202404-0727ED","article-title":"Pulmonary ionocytes: what are they transporting and which way","volume":"210","author":"Okuda","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-pathol-042420-094031","article-title":"Cystic fibrosis and the cells of the airway epithelium: what are ionocytes and what do they do","volume":"17","author":"Shah","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-immunol-042718-041505","article-title":"Tuft cells-systemically dispersed sensory epithelia integrating immune and neural circuitry","volume":"37","author":"O\u2019Leary","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"110018","DOI":"10.1016\/j.intimp.2023.110018","article-title":"Tuft cells - the immunological interface and role in disease regulation","volume":"118","author":"Iqbal","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02082-06","article-title":"Influenza a virus NS1 protein activates the PI3K\/akt pathway to mediate antiapoptotic signaling responses","volume":"81","author":"Ehrhardt","year":"2007","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01712-07","article-title":"Avian influenza virus a\/HK\/483\/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells","volume":"82","author":"Lam","year":"2008","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.17.7875-7881.2001","article-title":"Influenza virus NS1 protein induces apoptosis in cultured cells","volume":"75","author":"Schultz-Cherry","year":"2001","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.131","article-title":"The nucleoprotein of influenza a virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43","volume":"6","author":"H","year":"2015","journal-title":"Cell Death Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1038\/cddis.2013.89","article-title":"Influenza a virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein clusterin","volume":"4","author":"Tripathi","year":"2013","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.360","article-title":"Nucleoprotein of influenza a virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication","volume":"6","author":"Ak","year":"2015","journal-title":"Cell Death Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1371\/journal.ppat.0010004","article-title":"Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1","volume":"1","author":"Zamarin","year":"2005","journal-title":"PloS Pathog"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1038\/cddis.2011.75","article-title":"Cell death regulation during influenza a virus infection by matrix (M1) protein: a model of viral control over the cellular survival pathway","volume":"2","author":"Halder","year":"2011","journal-title":"Cell Death Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041956","article-title":"The role of bcl-xL protein in viral infections","volume":"22","author":"Z","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0460OC","article-title":"Influenza induces endoplasmic reticulum stress, caspase-12-dependent apoptosis, and c-jun N-terminal kinase-mediated transforming growth factor-\u03b2 release in lung epithelial cells","volume":"46","author":"Ec","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2139922","article-title":"A\/(H1N1) pdm09 NS1 promotes viral replication by enhancing autophagy through hijacking the IAV negative regulatory factor LRPPRC","volume":"19","author":"uo","year":"2023","journal-title":"Autophagy"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02148-13","article-title":"Influenza a virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells","volume":"87","author":"Zhirnov","year":"2013","journal-title":"J Virol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03120","article-title":"Influenza a virus NS1 protein suppresses JNK1-dependent autophagosome formation mediated by Rab11a recycling endosomes","volume":"9","author":"Kuroki","year":"2018","journal-title":"Front Microbiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix protein 2 of influenza a virus blocks autophagosome fusion with lysosomes","volume":"6","author":"Gannag\u00e9","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B68","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/15548627.2020.1725375","article-title":"Influenza a virus protein PB1-F2 impairs innate immunity by inducing mitophagy","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1009300","DOI":"10.1371\/journal.ppat.1009300","article-title":"The PB1 protein of influenza a virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation","volume":"17","author":"Zeng","year":"2021","journal-title":"PloS Pathog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2162798","article-title":"The nucleoprotein of influenza a virus inhibits the innate immune response by inducing mitophagy","volume":"19","author":"Zhang","year":"2023","journal-title":"Autophagy"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e2404365","DOI":"10.1002\/advs.202404365","article-title":"The hemagglutinin of influenza a virus induces ferroptosis to facilitate viral replication","volume":"11","author":"Ouyang","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"B72","doi-asserted-by":"publisher","first-page":"eadu7602","DOI":"10.1126\/sciadv.adu7602","article-title":"Influenza a virus subverts the LC3-pericentrin dynein adaptor complex for host cytoplasm entry","volume":"11","author":"Cong","year":"2025","journal-title":"Sci Adv"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.05.004","article-title":"H1N1 influenza virus infection through NRF2-KEAP1-GCLC pathway induces ferroptosis in nasal mucosal epithelial cells","volume":"204","author":"C","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.040","article-title":"Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense","volume":"181","author":"M","year":"2020","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1580089","article-title":"Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cell.2020.02.050","article-title":"Influenza virus Z-RNAs induce ZBP1-mediated necroptosis","volume":"180","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.09.014","article-title":"DAI senses influenza a virus genomic RNA and activates RIPK3-dependent cell death","volume":"20","author":"Thapa","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00110-23","article-title":"MLKL-driven inflammasome activation and caspase-8 mediate inflammatory cell death in influenza a virus infection","volume":"14","author":"L","year":"2023","journal-title":"Mbio"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e20191259","DOI":"10.1084\/jem.20191259","article-title":"Necroptosis restricts influenza a virus as a stand-alone cell death mechanism","volume":"217","author":"Shubina","year":"2020","journal-title":"J Exp Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01101-19","article-title":"Benefits and perils of necroptosis in influenza virus infection","volume":"94","author":"S","year":"2020","journal-title":"J Virol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41419-018-1035-6","article-title":"The induction and consequences of influenza a virus-induced cell death","volume":"9","author":"Atkin-Smith","year":"2018","journal-title":"Cell Death Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nature06945","article-title":"The genomic and epidemiological dynamics of human influenza a virus","volume":"453","author":"Rambaut","year":"2008","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013124","article-title":"Neuregulin-1 prevents death from a normally lethal respiratory viral infection","volume":"21","author":"Sa","year":"2025","journal-title":"PLOS Pathog"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag2045","article-title":"ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways","volume":"1","author":"T","year":"2016","journal-title":"Sci Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"nwab137","DOI":"10.1093\/nsr\/nwab137","article-title":"H7N9 virus infection triggers lethal cytokine storm by activating gasdermin E-mediated pyroptosis of lung alveolar epithelial cells","volume":"9","author":"Wan","year":"2021","journal-title":"Natl Sci Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes through intracellular M2 channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1003392","DOI":"10.1371\/journal.ppat.1003392","article-title":"Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease","volume":"9","author":"McAuley","year":"2013","journal-title":"PloS Pathog"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4AB0420-694R","article-title":"PB1-F2 protein of highly pathogenic influenza a (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction","volume":"108","author":"Cheung","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00120-16","article-title":"The RNA- and TRIM25-binding domains of influenza virus NS1 protein are essential for suppression of NLRP3 inflammasome-mediated interleukin-1\u03b2 secretion","volume":"90","author":"Moriyama","year":"2016","journal-title":"J Virol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1084\/jem.20170550","article-title":"ZBP1\/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death","volume":"214","author":"Kesavardhana","year":"2017","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nature16959","article-title":"Nek7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.12.014","article-title":"Galectin-3 enhances avian H5N1 influenza a virus-induced pulmonary inflammation by promoting NLRP3 inflammasome activation","volume":"188","author":"Chen","year":"2018","journal-title":"Am J Pathol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-024-10043-w","article-title":"TRIM46 accelerates H1N1 influenza virus-induced ferroptosis and inflammatory response by regulating SLC7A11 ubiquitination","volume":"56","author":"C","year":"2024","journal-title":"J Bioenerg Biomembr"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/ijms25063315","article-title":"TRIM21 promotes oxidative stress and ferroptosis through the SQSTM1-NRF2-KEAP1 axis to increase the titers of H5N1 highly pathogenic avian influenza virus","volume":"25","author":"Wei","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"115783","DOI":"10.1016\/j.celrep.2025.115783","article-title":"Pexophagy-driven redox imbalance promotes virus-induced ferroptosis","volume":"44","author":"Jiang","year":"2025","journal-title":"Cell Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"103572","DOI":"10.1016\/j.redox.2025.103572","article-title":"Indoleamine 2,3-dioxygenase 1 drives epithelial cells ferroptosis in influenza-induced acute lung injury","volume":"81","author":"Zheng","year":"2025","journal-title":"Redox Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduction Targeting Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e1003256","DOI":"10.1371\/journal.ppat.1003256","article-title":"Type I IFN triggers RIG-I\/TLR3\/NLRP3-dependent inflammasome activation in influenza a virus infected cells","volume":"9","author":"Pothlichet","year":"2013","journal-title":"PloS Pathog"},{"key":"B104","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(00)00026-5","article-title":"Molecular pathogenesis of influenza a virus infection and virus-induced regulation of cytokine gene expression","volume":"12","author":"Julkunen","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1038\/ncomms5713","article-title":"Influenza a virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity","volume":"5","author":"Yoshizumi","year":"2014","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-015-0191-z","article-title":"Induction of innate immunity and its perturbation by influenza viruses","volume":"6","author":"Goraya","year":"2015","journal-title":"Protein Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.006","article-title":"The intracellular sensor NLRP3 mediates key innate and healing responses to influenza a virus via the regulation of caspase-1","volume":"30","author":"Thomas","year":"2009","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600714","article-title":"AIM2 inflammasome is critical for influenza-induced lung injury and mortality","volume":"198","author":"Zhang","year":"2017","journal-title":"J Immunol Baltim Md 1950"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1006985","DOI":"10.1371\/journal.ppat.1006985","article-title":"Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment","volume":"14","author":"Gangaplara","year":"2018","journal-title":"PloS Pathog"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83931","article-title":"Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection","volume":"126","author":"Peteranderl","year":"2016","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"eabo6294","DOI":"10.1126\/sciimmunol.abo6294","article-title":"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection","volume":"7","author":"Karki","year":"2022","journal-title":"Sci Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.11.002","article-title":"ZBP1: innate sensor regulating cell death and inflammation","volume":"39","author":"Kuriakose","year":"2018","journal-title":"Trends Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973727","article-title":"Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen","volume":"266","author":"Smith","year":"1994","journal-title":"Science"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e1003188","DOI":"10.1371\/journal.ppat.1003188","article-title":"Macrophage-expressed IFN-\u03b2 contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia","volume":"9","author":"H\u00f6gner","year":"2013","journal-title":"PloS Pathog"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R116.774745","article-title":"Current prospects of type II interferon \u03b3 signaling and autoimmunity","volume":"292","author":"Green","year":"2017","journal-title":"J Biol Chem"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.24.13257-13266.2003","article-title":"A recombinant influenza a virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice","volume":"77","author":"Donelan","year":"2003","journal-title":"J Virol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00198-17","article-title":"Influenza a virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein to facilitate inhibition of the RNA-dependent protein kinase PKR","volume":"91","author":"Schierhorn","year":"2017","journal-title":"J Virol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s13238-020-00734-6","article-title":"TRIM35 mediates protection against influenza infection by activating TRAF3 and degrading viral PB2","volume":"11","author":"Sun","year":"2020","journal-title":"Protein Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e1003773","DOI":"10.1371\/journal.ppat.1003773","article-title":"Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia","volume":"9","author":"Crotta","year":"2013","journal-title":"PloS Pathog"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/nature09907","article-title":"A diverse array of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/ijms20061445","article-title":"Differential regulation of type I and type III interferon signaling","volume":"20","author":"Stanifer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.06.015","article-title":"RNA polymerase III detects cytosolic DNA and induces type-I interferons through the RIG-I pathway","volume":"138","author":"Chiu","year":"2009","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.10.011","article-title":"Type I IFN family members: similarity, differences and interaction","volume":"26","author":"Capobianchi","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-024-0921-5_1","article-title":"Regulation of IFN-\u03b3 expression","volume":"941","author":"Fenimore","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.08.008","article-title":"Type III interferons in antiviral defenses at barrier surfaces","volume":"39","author":"Ai","year":"2018","journal-title":"Trends Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1159\/000495172","article-title":"Type III interferons in viral infection and antiviral immunity","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608618200","article-title":"Viral infections activate types I and III interferon genes through a common mechanism","volume":"282","author":"Onoguchi","year":"2007","journal-title":"J Biol Chem"},{"key":"B135","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza a viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"a038414","DOI":"10.1101\/cshperspect.a038414","article-title":"Induction and evasion of type-I interferon responses during influenza a virus infection","volume":"11","author":"Mu\u00f1oz-Moreno","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv018","article-title":"Human influenza a virus\u2013specific CD8+ T-cell response is long-lived","volume":"212","author":"van","year":"2015","journal-title":"J Infect Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701538","article-title":"IRF1 is a transcriptional regulator of ZBP1 promoting NLRP3 inflammasome activation and cell death during influenza virus infection","volume":"1950","author":"Kuriakose","year":"2018","journal-title":"J Immunol Baltim Md"},{"key":"B140","doi-asserted-by":"publisher","first-page":"105141","DOI":"10.1016\/j.jbc.2023.105141","article-title":"Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis)","volume":"299","author":"Sharma","year":"2023","journal-title":"J Biol Chem"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151613","article-title":"Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis","volume":"213","author":"Jorgensen","year":"2016","journal-title":"J Exp Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.004","article-title":"Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways","volume":"35","author":"Ravichandran","year":"2011","journal-title":"Immunity"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e2207240119","DOI":"10.1073\/pnas.2207240119","article-title":"Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis","volume":"119","author":"Rodriguez","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat Commun"},{"key":"B145","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1165\/rcmb.2018-0196OC","article-title":"Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia","volume":"61","author":"Pulavendran","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am J Pathol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"11888","DOI":"10.1073\/pnas.1902310116","article-title":"BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection","volume":"116","author":"Zhu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B148","doi-asserted-by":"publisher","first-page":"197, 233","DOI":"10.4049\/jimmunol.1502115","article-title":"Multiple inhibitory pathways contribute to lung CD8+ T cell impairment and protect against immunopathology during acute viral respiratory infection","volume":"1950","author":"Erickson","year":"2016","journal-title":"J Immunol Baltim Md"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05257-0","article-title":"PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00385","article-title":"Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells","volume":"9","author":"Lichtenegger","year":"2018","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00186214","article-title":"Influenza virus-induced lung injury: pathogenesis and implications for treatment","volume":"45","author":"Herold","year":"2015","journal-title":"Eur Respir J"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68782","article-title":"Type 2 alveolar cells are stem cells in adult lung","volume":"123","author":"Barkauskas","year":"2013","journal-title":"J Clin Invest"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00422-25","article-title":"Potential for prolonged replication of common acute respiratory viruses in air-liquid interface cultures of primary human airway cells","volume":"10","author":"Kawase","year":"2025","journal-title":"Msphere"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.08.004","article-title":"The role of respiratory epithelium in host defence against influenza virus infection","volume":"41","author":"Denney","year":"2018","journal-title":"Biomed J"},{"key":"B155","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.antiviral.2017.10.020","article-title":"The role of the NLRP3 inflammasome in regulation of antiviral responses to influenza a virus infection","volume":"148","year":"2017","journal-title":"Antiviral Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nature11714","article-title":"Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation","volume":"493","author":"Juncadella","year":"2013","journal-title":"Nature"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978824","article-title":"Comprehensive single cell analysis of pandemic influenza a virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis","volume":"13","author":"Jn","year":"2022","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/nature20141","article-title":"Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation","volume":"539","author":"Han","year":"2016","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2006-0080SF","article-title":"Alveolar epithelial ion and fluid transport","volume":"35","author":"Folkesson","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-023-44421-6","article-title":"Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia","volume":"15","author":"Pervizaj-Oruqaj","year":"2024","journal-title":"Nat Commun"},{"key":"B161","doi-asserted-by":"publisher","first-page":"e20221462","DOI":"10.1084\/jem.20221462","article-title":"Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells","volume":"220","author":"Kaiser","year":"2022","journal-title":"J Exp Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110974","article-title":"Mitochondrial cyclophilin D promotes disease tolerance by licensing NK cell development and IL-22 production against influenza virus","volume":"39","author":"Downey","year":"2022","journal-title":"Cell Rep"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00743-0","article-title":"Safety and efficacy of onradivir in adults with acute uncomplicated influenza a infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70140","article-title":"Virus-induced cellular senescence causes pulmonary sequelae post-influenza infection","volume":"24","author":"Lipskaia","year":"2023","journal-title":"Aging Cell"},{"key":"B166","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12931-023-02477-4","article-title":"Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and staphylococcus aureus infections","volume":"24","author":"Liao","year":"2023","journal-title":"Respir Res"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2024.12.008","article-title":"ZBP1-driven cell death in severe influenza","volume":"33","author":"Boyd","year":"2025","journal-title":"Trends Microbiol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07265-8","article-title":"Necroptosis blockade prevents lung injury in severe influenza","volume":"628","author":"Gautam","year":"2024","journal-title":"Nature"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27355","article-title":"Ponatinib-review of historical development, current status, and future research","volume":"99","author":"Kantarjian","year":"2024","journal-title":"Am J Hematol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2489751","DOI":"10.1080\/21505594.2025.2489751","article-title":"Ponatinib and other clinically approved inhibitors of src and rho-a kinases abrogate dengue virus serotype 2- induced endothelial permeability","volume":"16","author":"Mishra","year":"2025","journal-title":"Virulence"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01887","article-title":"Silmitasertib (CX-4945), a clinically used CK2-kinase inhibitor with additional effects on GSK3\u03b2 and DYRK1A kinases: a structural perspective","volume":"66","author":"Grygier","year":"2023","journal-title":"J Med Chem"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.2024449","article-title":"Lead optimization, pharmacophore development and scaffold design of protein kinase CK2 inhibitors as potential COVID-19 therapeutics","volume":"41","author":"Yadav","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005804","article-title":"An epithelial integrin regulates the amplitude of protective lung interferon responses against multiple respiratory pathogens","volume":"12","author":"Va","year":"2016","journal-title":"PloS Pathog"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e1011406","DOI":"10.1371\/journal.ppat.1011406","article-title":"Melatonin alleviates lung injury in H1N1-infected mice by mast cell inactivation and cytokine storm suppression","volume":"19","author":"Huo","year":"2023","journal-title":"PloS Pathog"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom10091211","article-title":"Melatonin\u2019s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease","volume":"10","author":"Chitimus","year":"2020","journal-title":"Biomolecules"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01282-9","article-title":"Oseltamivir for influenza","volume":"387","author":"P","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/molecules28041849","article-title":"Design, synthesis, biological evaluation, and molecular dynamics simulation of influenza polymerase PB2 inhibitors","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e29010","DOI":"10.1002\/jmv.29010","article-title":"Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: a multicentre cohort study","volume":"95","author":"Moreno","year":"2023","journal-title":"J Med Virol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"114711","DOI":"10.1016\/j.ejmech.2022.114711","article-title":"The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza a: a review","volume":"243","author":"Wang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000910","article-title":"Antiviral therapies for influenza","volume":"36","author":"Chan","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01307-2","article-title":"Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020963616","article-title":"Intravenous zanamivir: a viable option for critically ill patients with influenza","volume":"55","author":"Slain","year":"2021","journal-title":"Ann Pharmacother"},{"key":"B184","doi-asserted-by":"publisher","first-page":"CD008965","DOI":"10.1002\/14651858.CD008965.pub4","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac462","article-title":"Response to \u2018inhaled zanamivir versus oral oseltamivir to prevent influenza-related hospitalization or death: a nationwide population-based quasi-experimental study\u2019","volume":"75","author":"Chang","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)00087-7","article-title":"Treating influenza with zanamivir","volume":"352","author":"Read","year":"1998","journal-title":"Lancet Lond Engl"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2022702","article-title":"Baloxavir for postexposure prophylaxis against influenza in households","volume":"383","author":"Uyeki","year":"2020","journal-title":"N Engl J Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa107","article-title":"Baloxavir: a novel antiviral agent in the treatment of influenza","volume":"71","author":"Abraham","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413156","article-title":"Efficacy of baloxavir treatment in preventing transmission of influenza","volume":"392","author":"Monto","year":"2025","journal-title":"N Engl J Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B192","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B194","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","article-title":"PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduction Targeting Ther"},{"key":"B195","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41467-022-29690-x","article-title":"An anti-influenza a virus microbial metabolite acts by degrading viral endonuclease PA","volume":"13","author":"Ge","year":"2022","journal-title":"Nat Commun"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.10.006","article-title":"Development of PROTACs using computational approaches","volume":"45","author":"Ge","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B197","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.cellin.2022.100030","article-title":"Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus","volume":"1","author":"Xu","year":"2022","journal-title":"Cell Insight"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"B199","doi-asserted-by":"publisher","first-page":"100647","DOI":"10.1016\/j.jbc.2021.100647","article-title":"Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs","volume":"296","author":"Alabi","year":"2021","journal-title":"J Biol Chem"},{"key":"B200","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.984","article-title":"Arbidol: the current demand, strategies, and antiviral mechanisms","volume":"11","author":"Y","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug arbidol","volume":"114","author":"Ru","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B204","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res"},{"key":"B205","doi-asserted-by":"publisher","first-page":"104751","DOI":"10.1016\/j.antiviral.2020.104751","article-title":"Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy","volume":"176","author":"Mifsud","year":"2020","journal-title":"Antiviral Res"},{"key":"B206","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-025-05611-1","article-title":"Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches","volume":"82","author":"Bonomini","year":"2025","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku074","article-title":"Novel oral anti-influenza drug candidate AV5080","volume":"69","author":"Ivachtchenko","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B208","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bcp.13405","article-title":"Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1\/M2 translation","volume":"84","author":"Beigel","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0289","article-title":"Quantitative determination of AVI-7100 (radavirsen), a phosphorodiamidate morpholino oligomer (PMOplus\u00ae ), in human plasma using LC-MS\/MS","volume":"9","author":"Meng","year":"2017","journal-title":"Bioanalysis"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza a viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa376","article-title":"A phase 2 study of pimodivir (JNJ-63623872) in combination with oseltamivir in elderly and nonelderly adults hospitalized with influenza a infection: OPAL study","volume":"226","author":"O'Neil","year":"2022","journal-title":"J Infect Dis"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3212","article-title":"Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: A phase IIa, randomized, double-blind, placebo-controlled study","volume":"23","author":"Trevejo","year":"2018","journal-title":"Antivir Ther"},{"key":"B215","doi-asserted-by":"publisher","first-page":"105035","DOI":"10.1016\/j.antiviral.2021.105035","article-title":"Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir","volume":"188","author":"Patel","year":"2021","journal-title":"Antiviral Res"},{"key":"B216","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/ph16030365","article-title":"Preclinical study of ZSP1273, a potent antiviral inhibitor of cap binding to the PB2 subunit of influenza a polymerase","volume":"16","author":"Chen","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B217","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2019.04.006","article-title":"Advances in respiratory virus therapeutics \u2013 a meeting report from the 6th isirv antiviral group conference","volume":"167","author":"Beigel","year":"2019","journal-title":"Antiviral Res"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2025.01.025","article-title":"Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-centre, randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"31","author":"Wang","year":"2025","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1505557","article-title":"Evaluation of drug-drug interaction between suraxavir marboxil (GP681) and itraconazole, and assessment of the impact of gene polymorphism","volume":"15","author":"Han","year":"2024","journal-title":"Front Pharmacol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03419-3","article-title":"Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial","volume":"31","author":"Wang","year":"2025","journal-title":"Nat Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.virs.2023.06.002","article-title":"PA-E18G substitution in influenza a virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor","volume":"38","author":"Luo","year":"2023","journal-title":"Virol Sin"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy410","article-title":"Antiviral activity, safety, and pharmacokinetics of AL-794, a novel oral influenza endonuclease inhibitor: Results of an influenza human challenge study","volume":"219","author":"Yogaratnam","year":"2019","journal-title":"J Infect Dis"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3244","article-title":"Phase I study on safety and pharmacokinetics of a novel influenza endonuclease inhibitor, AL-794 (JNJ-64155806), following single- and multiple-ascending doses in healthy adults","volume":"23","author":"Kakuda","year":"2018","journal-title":"Antivir Ther"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1272466","article-title":"Safety, tolerability, and pharmacokinetics of TG-1000, a new molecular entity against influenza virus: first-in-human study","volume":"14","author":"Xu","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1705500\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:43:14Z","timestamp":1769668994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1705500\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":224,"alternative-id":["10.3389\/fimmu.2026.1705500"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1705500","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1705500"}}